[Treatment of Hodgkin's disease in stages 3 B and IV with the chemotherapy-radiotherapy-chemotherapy sequence].
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use*; D002648:Child; D003036:Cobalt Isotopes / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D010535:Laparoscopy; D008220:Lymphography; D008297:Male; D008875:Middle Aged; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D011867:Radioisotope Teletherapy; D012737:Sex Factors; D014747:Vinblastine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001565:Benzoates; D003036:Cobalt Isotopes; D006834:Hydrazines; D011344:Procarbazine; D014747:Vinblastine; D003348:Cortisone
Traitement des maladies de Hodgkin, states 3 B et IV, par la séquence chimiothérapie, radiothérapie, chimiothérapie.